hepatitis B – Página 3 – Fundacion Investigaciones Biomédicas

The long-term effect of treatment with interferon-alpha 2a in chronic hepatitis B

Krogsgaard K, the Long-term Follow-up Investigator Group and the European Study Group on Viral Hepatitis (EUROHEP).J Viral Hepat 1998; 5: 389-397.

Fecha 13 Mar 1998
Por Luis
En Publicaciones

Ver Abstract

Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and whithout normal ALT levels

Cabrerizo M, Bartolomé J, Rodríguez-Iñigo E, López-Alcorocho JM, Cotonat T,Carreño V. J Med Virol 1998; 56: 294-299.

Fecha 27 Feb 1998
Por Luis
En Publicaciones

Ver Abstract

Double-blind, randomized controlled trial of interleukin-2 treatment of chronic hepatitis B

Artillo S, Pastore G, Alberti A, Milella M, Santantonio T, Fattovich G, Giustina G, Ryff JCh, Chanéac M, Bartolomé J,Carreño V. J Med Virol 1998; 54: 167-172.

Fecha 24 Feb 1998
Por Luis
En Publicaciones

Ver Abstract

Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff

Cabrerizo M, Bartolomé J, de Sequera P, Caramelo C,Carreño V. J Am Soc Nephrol 1997; 8: 1443-1147.

Fecha 23 Nov 1997
Por Luis
En Publicaciones

Ver Abstract

Detection of hepatitis GB virus type C RNA in serum and liver from children with chronic viral hepatitis B and C

López-Alcorocho JM, Millán A, García-Trevijano ER, Bartolomé J, Ruíz-Moreno M, Otero M,Carreño V. Hepatology 1997; 25: 1258-1260.

Fecha 19 Nov 1997
Por Luis
En Publicaciones

Ver Abstract

Impaired interferon induction of the human MxA protein in chronic hepatitis B virus infection.

Fernández M, Quiroga JA, Martín J, Cotonat T, Pardo M, Horisberger MA,Carreño V. J Med Virol 1997; 51: 332-337.

Fecha 13 Oct 1997
Por Luis
En Publicaciones

Ver Abstract

Decreased nitric oxide production in chronic viral hepatitis B and C.

Amaro MJ, Bartolomé J, Pardo M, Cotonat T, López-Farré A,Carreño V. J Med Virol 1997; 51: 326-331.

Fecha 28 Sep 1997
Por Luis
En Publicaciones

Ver Abstract

GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D.

Madejón A, Fogeda M, Bartolomé J, Pardo M, González C, Cotonat T,Carreño V. Gastroenterology 1997; 113: 573-578.

Fecha 28 Jun 1997
Por Luis
En Publicaciones

Ver Abstract

Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy.

López-Alcorocho JM, Bartolomé J, Cotonat T,Carreño V. J Viral Hepatitis 1997; 4 (Suppl1): 27-32.

Fecha 21 May 1997
Por Luis
En Publicaciones

Ver Abstract

Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment.

Rodríguez-Iñigo E, Bartolomé J, López-Alcorocho JM, Cotonat T, Oliva H,Carreño V. J Med Virol 1997; 53: 76-80

Fecha 22 Abr 1997
Por Luis
En Publicaciones

Ver Abstract

Pilot interferon beta trial in children with chronic hepatitis B who had previously not responded to interferon alpha therapy

Ruíz-Moreno M, Fernández P, Leal A, Bartolomé J, Castillo I, Oliva H,Carreño V.Pediatrics 1997; 99: 222-225.

Fecha 18 Abr 1997
Por Luis
En Publicaciones

Ver Abstract

Biological properties of interleukin-12 and its therapeutic use in persistent hepatitis B virus and hepatitis C virus infection.

Carreño V, Quiroga JA. J Viral Hep 1997; 4 (Suppl.2): 83-86.

Fecha 10 Ene 1997
Por Luis
En Publicaciones

Ver Abstract

Etiqueta : hepatitis B